FDA issued a Warning Letter to Pharmalucence, Inc. on 9/23/2008 for a previous inspection.
483 Pharmalucence Sep 2014

483 Pharmalucence Sep 2014

Cassandra Abellard FDA, Arie Menachem FDA$119.00 - Available Now

FDA investigators audited the Pharmalucence - Bedford, MA, United States facility and issued 6 inspectional observations (via FDA 483) on 17 Sep 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 6
  • Inspection end: 17 Sep 2014
  • Location: Bedford, United States
  • FEI: 1219718
Add To Cart